|
Bio-Computing Day at SC09 to Feature One of the World's Leading Scientists in Molecular Biotechnology and Genomics (Business Wire via Yahoo! Finance)
PORTLAND, Ore.----SC09, the 22nd annual event in the SC conference series, recognized globally as the premier international conference on high performance computing, networking, storage and analysis, announced today it has selected world renowned Biologist, Dr.
(Sep 4, 2009)
Microfluidic devices market to exceed $3 billion in 2014, says Yole (EETimes)
The market of microfluidic devices is set to exceed $3 billion in 2014, and drug discovery remains the first microfluidics market, according to market trackers Yole Dveloppement (Lyon, France). Sponsored Topics: Lyon - Drug discovery - Business - Microfluidics - Pharmaceuticals
(Sep 4, 2009)
Microfluidic devices market to exceed $3 billion in 2014, says Yole (EETimes)
The market of microfluidic devices is set to exceed $3 billion in 2014, and drug discovery remains the first microfluidics market, according to market trackers Yole Dveloppement (Lyon, France).
(Sep 4, 2009)
Biophysical Society names 2010 award recipients (EurekAlert!)
( Biophysical Society ) The Biophysical Society is pleased to announce the recipients of its 2010 Society awards. The eight recipients will receive their awards at the Society's 54th Annual Meeting on Monday, February 22, 2010, at the Moscone Convention and Exhibitions Center in San Francisco, Calif.
(Sep 4, 2009)
Funding Update (GenomeWeb News)
NSF Bioinformatics Grants Awarded July 24 — August 25, 2009 (Part two of two. Part one ran last week .) Supports the development of computational methods for reconstructing the full spectrum of haplotype sequences from high-throughput sequencing data.
(Sep 4, 2009)
U of T researchers identify protein (EurekAlert!)
( University of Toronto ) Researchers at the University of Toronto have identified a protein which plays a key role in the development of neurons, which could enhance our understanding of how the brain works, and how diseases such as Alzheimer's occur.
(Sep 4, 2009)
Tear Down This Firewall: Pharma Scientists Call for a Pre-competitive Approach to Bioinformatics (GenomeWeb News)
While large pharmaceutical firms aren't known for being generous with their data, a small group of pharma scientists is looking to change that perception with a call for pre-competitive bioinformatics projects and enhanced data sharing in the industry.
(Sep 4, 2009)
Virginia Tech to Scale Up Synthetic DNA Design Software Tool with $1.4M NSF Grant (GenomeWeb News)
Scientists at Virginia Tech will use a three-year, $1.4 million grant from the National Science Foundation to expand GenoCAD — a user-friendly software package that enables scientists to design genetic constructs using a genetic "parts list."
(Sep 4, 2009)
IDS, Biosignatures Set License Agreement (GenomeWeb News)
NEW YORK (GenomeWeb News) – Immunodiagnostic Systems has licensed the right to use new biomarkers developed by Biosignatures for use in immunoassay diagnostic test kits for kidney diseases, IDS said today.
(Sep 4, 2009)
In Brief This Week: Illumina; Agilent; Integrated DNA Technologies; Hybrigenics; Monogram Biosciences; UTEP (GenomeWeb News)
NEW YORK (GenomeWeb News) – Illumina earlier this week said that it had delivered the first genome through its individual genome sequencing service. The first customer was Hermann Hauser, a partner in Amadeus Capital Partners.
(Sep 4, 2009)
23andMe Founder Linda Avey Leaves To Start Alzheimer’s Research Foundation (TechCrunch)
Linda Avey , one of the two founders of personal genomics company 23andMe , is leaving the startup to start a new foundation dedicated to studying Alzheimer's disease. Avey, who has been with the company for over three years, writes that the new foundation will make use of 23andMe's research platform to "drive the formation of the world's largest community of individuals with a family history of ...
(Sep 4, 2009)
Species Diversity Helps Researchers Refine Analyses Of Human Gene Mutations (Science Daily)
Researchers examining DNA mutations from both healthy and diseased patients are evaluating the reliability of computer models aimed at predicting the eventual effect of such mutations.
(Sep 4, 2009)
Enabling microRNA Discoveries - LC Sciences Tops 100th Customer Publication (PRWeb via Yahoo! News)
LC Sciences announced today the publication of the 100th peer-reviewed study by one of its customers using the company's microarray service for analyzing microRNA (miRNA) expression profiles and for discovery of novel small RNAs. These studies, by leading researchers in the field, contribute to a fast growing body of knowledge defining this recently discovered class of regulatory RNAs.
(Sep 5, 2009)
Genetic Cause For Type Of Deafness Identified By Scripps Research Scientists (Medical News Today)
A team led by scientists from The Scripps Research Institute has discovered a genetic cause of progressive hearing loss. The findings will help scientists better understand the nature of age-related decline in hearing and may lead to new therapies to prevent or treat the condition.
(Sep 5, 2009)
Genome Graphs, MCODE (GenomeWeb News)
The Genome Bioinformatics Group at the University of California , Santa Cruz , has released Genome Graphs , a new software tool for the UCSC Genome Browser that allows users to upload and display genome-wide data sets such as the results of genome-wide SNP association studies, linkage studies, and homozygosity mapping.
(Sep 5, 2009)
Roche and Affy Win EU Approval for AmpliChip, Microarray Dx Platform (GenomeWeb News)
Roche and Affymetrix announced last week that they had received European regulatory approval to market a microarray-based platform for in vitro diagnostic purposes as well as the first test to be used on Affymetrix’s system.
(Sep 5, 2009)
Next-Gen Sequencer Encourages Study of Non-Coding, Repetitive Sequences (GenomeWeb News)
NEW YORK, Jan. 30 (GenomeWeb News) - When a researcher at Penn State University offered Dan Peterson the chance to use a Genome Sequencer 20 for his pine genomics research, he jumped at the chance, and is glad he did.
(Sep 5, 2009)
Genome Therapeutics Achieves Milestone in Schering-Plough Research (GenomeWeb News)
ALTHAM , Mass.-- Genome Therapeutics last month announced that it had reached a milestone in its genomics alliance with Schering-Plough . The genomics company is using its proprietary bioinformatics tools and high-throughput sequencing capacity to identify within a specific chromosomal region candidate genes believed to be involved in the development of asthma.
(Sep 5, 2009)
Woods Hole of the West? That's what Newport hopes to become (The Oregonian)
The "mind boggling" amount of science going on in this coastal city could increase even more and that could help the economy as well as research
(Sep 5, 2009)
DNA Barcodes Of Bushmeat Published (redOrbit)
A new tool proved for tracking the global trade in wildlifeLeather handbags and chunks of red meat: when wildlife specialists find these items in shipping containers, luggage, or local markets, they can now use newly published genetic sequences known as "DNA barcodes" to pinpoint the species of origin. Experts hope that this simple technique will track the harvesting of bushmeat (or wildlife ...
(Sep 5, 2009)
Parkinson’s Disease: Iron Accumulation To The Point Of Demise (Science Daily)
Neurons that produce the neurotransmitter dopamine are the cerebral cells that most commonly die-off in Parkinson’s disease. The cells in the so-called substantia nigra, which contain the dark pigment neuromelanin, are affected. It is also known that the iron content of these cells increases during the course of Parkinson’s disease.
(Sep 6, 2009)
Discovery Leads To Rapid Mouse 'Personalized Trials' In Breast Cancer (Science Daily)
Using a finding that the genetic complexity of tumors in mice parallels that in humans, researchers are starting trial studies in mice, just like human clinical trials, to evaluate whether understanding tumor diversity can improve cancer treatment.
(Sep 6, 2009)
Woods Hole of the West? That's what Newport hopes to become (The Oregonian)
The "mind boggling" amount of science going on in this coastal city could increase even more and that could help the economy as well as research
(Sep 6, 2009)
Michigan turns to entrepreneurs to create new jobs (Detroit News)
FLINT -- Sometime next year, Michigan will lose its 1 millionth job since the state's economy began its downward slide in mid-2000. With a frenzy born of desperation, the state is trying to rekindle the entrepreneurial spirit that made Dow, Kellogg and Ford household names.
(Sep 6, 2009)
Compugen Collaborates with UCSF Scientists To Validate Chemokine Found Using Leads (GenomeWeb News)
Researchers at the University of California, San Francisco have used data generated by Compugen and its Leads bioinformatics platform to identify a putative chemokine that could result in a better understanding of how humans mount an immune response and might even contribute to developing new methods for fighting the HIV virus.
(Sep 6, 2009)
Partek Grants Software License to NHLBI (GenomeWeb News)
NEW YORK , Sept. 27 (GenomeWeb News) - Partek said today that the National Health, Lung, and Blood Institute at the National Institutes of Health has taken a license to the company's Partek Pro data analysis and mining software.
(Sep 6, 2009)
There'll Be Geeks and Dorks Everywhere! (GenomeWeb News)
NYC Mayor Michael Bloomberg was to kick off the first World Science Festival this morning. This five-day event includes talks on how experiments go wrong, neuroscience in the Bourne movies, Oliver Sacks and music, as well as Francis Collins, Jim Evans, and Paul Nurse on personal genomics.
(Sep 6, 2009)
Researchers Identify Key Neuron Development Protein (redOrbit)
Researchers at the University of Toronto have identified a protein which plays a key role in the development of neurons, which could enhance our understanding of how the brain works, and how diseases such as Alzheimer's occur.U of T graduate student John Calarco, working in the labs of Prof.
(Sep 6, 2009)
Rapid Mouse 'Personalized Trials' In Breast Cancer (redOrbit)
One person's breast cancer is not the same as another person's, because the gene mutations differ in each tumor.
(Sep 6, 2009)
Scientists find three new gene links to Alzheimer's (Reuters via Yahoo! News)
Scientists have found three new major genetic links to Alzheimer's, affecting up to 20 percent of people with the brain-wasting disease, and said on Sunday it was the most significant such discovery in 15 years.
(Sep 6, 2009)
New Alzheimer's Gene Targets Found (WebMD)
British and French researchers have found three more genes that make Alzheimer's disease more likely when certain mutations are present.
(Sep 6, 2009)
Newly Identified Alzheimer’s Genes Widen Route to Treatments (Bloomberg)
Sept. 6 (Bloomberg) -- The first new genes tied to Alzheimer’s disease in a decade have been identified by European scientists, adding insight into the biology of the most common cause of dementia and potentially leading to treatments.
(Sep 6, 2009)
Newly Identified Alzheimer’s Genes Widen Route to Treatments (Bloomberg)
Sept. 6 (Bloomberg) -- The first new genes tied to Alzheimer’s disease in a decade have been identified by European scientists, adding insight into the biology of the most common cause of dementia and potentially leading to treatments.
(Sep 6, 2009)
Supercomputing for the masses (Stuff)
Wellington start-up Intergrid is on a mission to bring computer processing power to the masses and says there are billions of dollars to be made. Intergrid's "green button" application lets people access supercomputer processing power at the click of a button.
(Sep 6, 2009)
Newport OR: Woods Hole of the West? (Seattle Times)
When the National Oceanic and Atmospheric Administration announced last month that it would move its Pacific fleet to Newport, the analogy on many lips was Woods Hole, as in Newport is going to be the Woods Hole of the West.
(Sep 6, 2009)
AnaSpecs Published References Pass 700 (PR.com)
The number of published papers that cite AnaSpecs products has passed 700. [PR.com - January 09, 2009]
(Sep 6, 2009)
AnaSpec Introduces New ClearPointTM beta-Amyloid Peptides (PR.com)
ClearPointTM peptides are AnaSpecs trademark collection of heavy or stable isotope labeled peptides and amino acids. [PR.com - January 11, 2009]
(Sep 6, 2009)
AnaSpec Introduces New AnaTagTM HiLyte FluorTM 594 & 680 Protein Labeling Kits (PR.com)
AnaSpec has announced the inclusion of two new dyes in its AnaTagTM protein labeling kit collection - HiLyte FluorTM 594 (Ex/Em=593/616 nm) and HiLyte FluorTM 680 (Ex/Em=678/699 nm). Developed by AnaSpec, HiLyte FluorTM dyes are a series of dyes that spans the whole visible spectrum (Figure 1). AnaTag™ HiLyte Fluor™ Protein Labeling kits provide a convenient way to label proteins using the ...
(Sep 6, 2009)
AnaSpec Awarded Patent for HiLyte FluorTM Dyes (PR.com)
AnaSpec, Inc. today announced that the U.S. Patent and Trademark Office has issued the company patent number 7,465,810 for Reactive 1,3-Crosslinked Carbocyanines and Their Bioconjugates. [PR.com - February 01, 2009]
(Sep 6, 2009)
AnaSpec Introduces Industrys Most Sensitive Luminescent Alkaline Phosphatase Assay Kits (PR.com)
AnaSpec announced the release of the industry’s most sensitive assay kits for the detection of alkaline phosphatase activities. The SensoLyteTM Luminescent Alkaline Phosphatase and SensoLyteTM Luminescent Alkaline Phosphatase ELISA assay kits contain a chemiluminescent substrate capable of detecting enzyme activities in solutions and in biological samples at femtogram level. The luminescent ...
(Sep 6, 2009)
AnaSpec Introduces Cost-Effective Replacement for Tetramethyl Rhodamine Maleimides (PR.com)
AnaSpec has introduced a collection of Tetramethylrhodamine C2 maleimides that represent an equally effective and more cost-effective replacement for Tetramethyl rhodamine maleimides. [PR.com - February 27, 2009]
(Sep 6, 2009)
AnaSpec Introduces Newest GO Peptides - Exendins (PR.com)
Along with a host of popular Exendin peptides, AnaSpecs GO Peptides line includes Fluorescein-Trp25-Exendin-4 (FLEX) and [Cys(HiLyteFluor 647 C2 maleimide)]-Exendin-4 - two exendin peptides that are not immediately available anywhere else. [PR.com - March 01, 2009]
(Sep 6, 2009)
AnaSpec Signs Distribution Agreement with BioPike, LLC (PR.com)
AnaSpec, Inc. and BioPike, LLC today announced a non-exclusive distributor agreement that will allow BioPike, LLC to distribute AnaSpec’s catalog and custom products throughout China. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased to partner with BioPike, LLC to expand the availability of our integrated proteomics solutions to researchers throughout [PR ...
(Sep 6, 2009)
AnaSpec Offers Calcein AM for Live Cell Staining (PR.com)
AnaSpec is pleased to offer Calcein, AM, a cell-permeant and non-fluorescent compound that is widely used for determining cell viability. Non-fluorescent Calcein, AM in live cells is hydrolyzed by intracellular esterases into the strongly green fluorescent anion calcein, and is retained in the cytoplasm of live cells. The excitation and emission wavelengths of calcein are 495 nm and 516 nm ...
(Sep 6, 2009)
AnaSpecs ClearPoint Peptides Win Best New Product Award (PR.com)
AnaSpec’s ClearPoint™ Peptides were awarded the Best New Product Award in the category of Biological Samples and Reagents at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference which was held in San Francisco, CA from February 25-27. By spiking protein tryptic digests with internal heavy isotope labeled peptide standards, Mass Spectrometry becomes an absolute quantitation (AQUA ...
(Sep 6, 2009)
AnaSpec Introduces Series of Cell Penetrating Peptides (CPP) (PR.com)
AnaSpec has CPPs such as (Arg)9, Antennapedia, TAT and others. Offerings include green fluorescent labeled (e.g. FAM or FITC) CPP, red labeled (e.g. TAMRA), Cys conjugated CPPs or Cys(Npys) conjugated CPP. [PR.com - April 08, 2009]
(Sep 6, 2009)
AnaSpec Introduces New SensoLyte Luminescent Peroxidase Assay Kits (PR.com)
AnaSpec has introduced two new luminescent read-out assay kits for determining peroxidase activity the SensoLyte Luminescent Peroxidase Assay Kit and the SensoLyte Luminescent Peroxidase ELISA Assay Kit. [PR.com - April 12, 2009]
(Sep 6, 2009)
AnaSpec Introduces New HiLyte Fluor 594 Labeled Secondary Antibodies & Streptavidin (PR.com)
AnaSpec has introduced a line of secondary antibodies and streptavidin conjugated to the newest member of the HiLyte Fluor™ family - HiLyte Fluor™ 594 (Ex/Em=593/616 nm). Using optimal fluorophore/protein labeling ratio, these HiLyte Fluor™ 594-IgG conjugates exhibit high fluorescent signal and uncompromised biological function. The fluorescence of HiLyte Fluor™ 594 can be detected with filters ...
(Sep 6, 2009)
Battle against cancer personal for head of research institute (Telegraph-Journal)
Warren McKenzie is an unlikely warrior in the battle against cancer.
(Sep 7, 2009)
Gene therapy could cut new Alzheimer’s cases by a fifth (Belfast Telegraph)
Gene scientists have taken a “leap forward” in Alzheimer's research with the potential to cut rates of the disease by a fifth, it has been revealed. Related Stories Minister's plea over blood donation Breakthrough in the fight against ‘type 2’ diabetes
(Sep 7, 2009)
|
